Related Experiment Video
Updated: Sep 5, 2025

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
What Inhibits Natural Killers' Performance in Tumour
Ines Papak1, Elżbieta Chruściel1, Katarzyna Dziubek1
1International Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822 Gdansk, Poland.
Abstract:
Natural killer cells are innate lymphocytes with the ability to lyse tumour cells depending on the balance of their activating and inhibiting receptors. Growing numbers of clinical trials show promising results of NK cell-based immunotherapies. Unlike T cells, NK cells can lyse tumour cells independent of antigen presentation, based simply on their activation and inhibition receptors. Various strategies to improve NK cell-based therapies are being developed, all with one goal: to shift the balance to activation. In this review, we discuss the current understanding of ways NK cells can lyse tumour cells and all the inhibitory signals stopping their cytotoxic potential.
Insights
Natural killer (NK) cells are innate immune cells that kill tumor cells by balancing activating and inhibitory signals. This review explores how NK cells eliminate tumors and the inhibitory factors that limit their cancer-fighting potential.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial innate immune cells involved in tumor surveillance and elimination.
- NK cell cytotoxicity is regulated by a complex interplay between activating and inhibitory receptors.
- NK cell-based immunotherapies are emerging as a promising cancer treatment modality.
Purpose of the Study:
- To review the mechanisms by which NK cells lyse tumor cells.
- To discuss the inhibitory signals that impair NK cell cytotoxic activity.
- To highlight strategies aimed at enhancing NK cell-based cancer immunotherapy.
Main Methods:
- This review synthesizes current knowledge from preclinical studies and clinical trials.
- Literature search and analysis of published research on NK cell function and immunotherapy.
- Discussion of receptor-ligand interactions and signaling pathways governing NK cell activation and inhibition.
Main Results:
- NK cells possess intrinsic tumor-lysing capabilities independent of antigen presentation.
- The balance of activating and inhibitory receptor engagement dictates NK cell effector function.
- Several strategies are being developed to overcome inhibitory signals and boost NK cell anti-tumor activity.
Conclusions:
- Understanding NK cell activation and inhibition is key to developing effective immunotherapies.
- Modulating NK cell receptor pathways offers a promising avenue for cancer treatment.
- Further research is needed to fully harness the therapeutic potential of NK cells in oncology.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibition of Cdk Activity
Tumor Immunotherapy
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

